Actively Recruiting
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
Led by Guangdong Provincial People's Hospital · Updated on 2025-08-17
18
Participants Needed
1
Research Sites
89 weeks
Total Duration
On this page
Sponsors
G
Guangdong Provincial People's Hospital
Lead Sponsor
G
Guangzhou Virotech Pharmaceutical Co., Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a single-center, single-arm, open investigator-initiated clinical study to evaluate the efficacy and safety of VRT106 in combination with chemotherapy in the treatment of resectable pancreatic cancer.
CONDITIONS
Official Title
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject voluntarily agrees to participate and signs informed consent before screening
- Male or female aged 18 to 75 years at screening
- Clinical diagnosis of pancreatic cancer
- Eastern Cooperative Oncology Group (ECOG) score of 0 or 1
- Expected survival time of at least 6 months
- No serious blood, heart, liver, kidney, or coagulation problems
You will not qualify if you...
- Previous treatment with oncolytic virus or systemic therapy for pancreatic cancer
- Prior allogeneic hematopoietic stem cell or organ transplantation
- Immunocompromised condition
- Known alcohol or drug dependency
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Actively Recruiting
Research Team
C
Chen RF Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here